CHARLOTTE, NC (GenomeWeb) — Laboratories with clinically validated next-gen sequencing assays are having trouble detecting certain complex variants, according to a recent interlaboratory study led by researchers at Invitae, suggesting that better standards are needed to ensure the quality of NGS-based genetic testing.